EDNY Certifies Interlocutory Appeal of False Claims Case To Second Circuit
Novartis Agrees To $678 Million False Claims Act Settlement With SDNY For Sham Speaker Programs
Compound Pharmacies Enter False Claims Act And Anti-Kickback Statute Settlement
EDNY Courts Enjoin Transmission of Fraudulent Robocalls
Second Circuit Holds Case Challenging Marijuana Classification As Schedule I Drug In Abeyance Pending Agency Exhaustion
Second Circuit Holds Case Challenging Marijuana Classification As Schedule I Drug In Abeyance Pending Agency Exhaustion
Supreme Court Unanimously Decides Relator May Use Ten-Year Limitation Period In Declined FCA Case
DOJ Outlines Guidance For Cooperation Credit in False Claims Act Cases
